Genovis Release: Interim Report January – March 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

January – March · Net sales rose by about 4% to SEK 1,984k (1,906k).

· Comprehensive income improved by SEK 108k to SEK -3,838k (-3,946k).
· Comprehensive income per share, basic and diluted, improved by SEK 0.14 to SEK -0.19 (-0.33).
· Cash flow from operating activities was SEK -6,213k (-4,429k)

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC